The puzzle of preserved cognition in the oldest old.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 27 07 2019
accepted: 15 10 2019
pubmed: 13 11 2019
medline: 25 11 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

Although epidemiological studies predict an exponential increase in the prevalence of dementia with age, recent studies have demonstrated that the oldest old are actually less frequently affected by dementia than the younger elderly. To explain this, I suggest a parallel between brain ageing and Alzheimer's disease (AD) and assume that theories concerning the brain's vulnerability to AD and its individual variability may also explain why some of the oldest old remain cognitively efficient. Some theories argue that AD is due to the continuing presence of the immature neurones vulnerable to amyloid beta protein (Aß) that are normally involved in brain development and then removed as a result of cell selection by the proteins associated with both brain development and AD. If a dysfunction in cell selection allows these immature neurones to survive, they degenerate early as a result of the neurotoxic action of Aß accumulation, which their mature counterparts can withstand. Consequently, age at the time of onset of AD and its clinical presentations depend on the number and location of such immature cells. I speculate that the same mechanism is responsible for the variability of normal brain ageing: the oldest old with well-preserved cognitive function are people genetically programmed for extreme ageing who have benefited from better cell selection during prenatal and neonatal life and therefore have fewer surviving neurones vulnerable to amyloid-promoted degeneration, whereas the process of early life cell selection was less successful in the oldest old who develop dementia.

Identifiants

pubmed: 31713754
doi: 10.1007/s10072-019-04111-y
pii: 10.1007/s10072-019-04111-y
doi:

Substances chimiques

Amyloid beta-Peptides 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

441-447

Références

World J Biol Psychiatry. 2016 Dec;17(8):587-599
pubmed: 23705632
Science. 1992 Apr 10;256(5054):184-5
pubmed: 1566067
Rambam Maimonides Med J. 2012 Oct 31;3(4):e0026
pubmed: 23908850
Neuropathol Appl Neurobiol. 2013 Feb;39(2):90-108
pubmed: 23046254
Mol Neurobiol. 2013 Dec;48(3):556-70
pubmed: 23546742
Acta Neuropathol. 2006 May;111(5):459-64
pubmed: 16496164
Arch Neurol. 2008 Sep;65(9):1211-7
pubmed: 18779425
Neuropsychology. 2005 Jul;19(4):520-31
pubmed: 16060827
Alzheimers Res Ther. 2014 Jul 01;6(4):39
pubmed: 25324900
J Neuropathol Exp Neurol. 2008 Jan;67(1):78-84
pubmed: 18091557
Nat Genet. 2013 Dec;45(12):1452-8
pubmed: 24162737
Ann Neurol. 2008 Oct;64(4):388-401
pubmed: 18991338
Curr Alzheimer Res. 2012 Jul;9(6):709-17
pubmed: 22471863
EMBO Rep. 2016 Apr;17(4):530-51
pubmed: 26931567
Neurology. 2001 Jun 26;56(12):1690-6
pubmed: 11425935
Neuroscience. 2014 Jun 6;269:152-72
pubmed: 24699227
Exp Gerontol. 2004 Nov-Dec;39(11-12):1587-93
pubmed: 15582273
Nat Rev Neurosci. 2006 Jan;7(1):30-40
pubmed: 16371948
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
J Comp Neurol. 1997 Jul 28;384(2):312-20
pubmed: 9215725
Neuroscience. 2008 Apr 9;152(4):970-81
pubmed: 18329176
Alzheimers Res Ther. 2013 Jul 01;5(4):27
pubmed: 23809176
Lancet Neurol. 2011 Sep;10(9):785-96
pubmed: 21802369
Neurobiol Aging. 2000 Nov-Dec;21(6):783-96
pubmed: 11124422
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):343-7
pubmed: 14660786
J Alzheimers Dis. 2018;62(3):933-942
pubmed: 29562544
Lancet Neurol. 2007 Jun;6(6):494-500
pubmed: 17509484
Nature. 2014 Nov 13;515(7526):274-8
pubmed: 25307057
Neurology. 2012 Aug 28;79(9):915-21
pubmed: 22895581
Science. 2009 Mar 13;323(5920):1473-7
pubmed: 19286555
Brain. 2007 Oct;130(Pt 10):2636-45
pubmed: 17898010
Ann Neurol. 1988 Feb;23(2):138-44
pubmed: 2897823
J Am Geriatr Soc. 2001 Jul;49(7):900-8
pubmed: 11527481
Curr Gerontol Geriatr Res. 2010;:
pubmed: 20706534
Mol Psychiatry. 2016 Jan;21(1):108-17
pubmed: 25778476
Acta Neuropathol Commun. 2014 Oct 21;2:146
pubmed: 25330988
J Alzheimers Dis. 2017;57(4):975-999
pubmed: 27567878
Acta Neuropathol. 2016 Jan;131(1):5-25
pubmed: 26715565
Neuroscientist. 2005 Oct;11(5):441-51
pubmed: 16151045
Nat Med. 1998 Apr;4(4):452-5
pubmed: 9546792
Acta Neuropathol. 2013 Sep;126(3):365-84
pubmed: 23900711
J Alzheimers Dis. 2018;65(3):731-746
pubmed: 28697557
Neurology. 2007 Dec 11;69(24):2197-204
pubmed: 17568013
J Cell Sci. 2004 Nov 15;117(Pt 24):5721-9
pubmed: 15537830
Brain Connect. 2011;1(4):279-93
pubmed: 22432418
Lancet. 1995 Oct 7;346(8980):931-4
pubmed: 7564727
J Neuropathol Exp Neurol. 2007 Dec;66(12):1136-46
pubmed: 18090922
Lancet Neurol. 2011 Sep;10(9):774-5
pubmed: 21802368
J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):715-9
pubmed: 12754337
Brain. 2013 Aug;136(Pt 8):2510-26
pubmed: 23824488
Acta Neuropathol. 2015 Oct;130(4):501-10
pubmed: 26298468
Neurobiol Aging. 2006 Jul;27(7):909-17
pubmed: 15979211
J Comp Neurol. 2003 Jul 21;462(2):144-52
pubmed: 12794739
Alzheimers Dement. 2015 Mar;11(3):258-70.e3
pubmed: 25150732
Nat Rev Neurol. 2013 Jul;9(7):382-93
pubmed: 23732531
Elife. 2017 Nov 09;6:
pubmed: 29120328
Prog Neurobiol. 2001 Feb;63(3):337-63
pubmed: 11115729
Cereb Cortex. 2009 Jul;19 Suppl 1:i42-8
pubmed: 19346270
JAMA Neurol. 2014 Jan;71(1):11-22
pubmed: 24276092
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9
pubmed: 22002422
Nature. 2009 Feb 19;457(7232):981-9
pubmed: 19225519
J Biol Chem. 2009 Aug 28;284(35):23806-17
pubmed: 19542221
Neuron. 2014 Jul 2;83(1):11-26
pubmed: 24991952
Nat Med. 2019 Apr;25(4):554-560
pubmed: 30911133
Neurology. 2006 Jun 27;66(12):1837-44
pubmed: 16801647
Arch Intern Med. 2001 Dec 10-24;161(22):2694-700
pubmed: 11732934
Neurol Sci. 2011 Dec;32(6):1241-7
pubmed: 21567180
J Alzheimers Dis. 2012;28(2):377-87
pubmed: 22027014
Neuroimage Clin. 2014 Mar 19;4:508-16
pubmed: 24818077
Trends Neurosci. 2004 Oct;27(10):607-13
pubmed: 15374672
Nat Genet. 2019 Mar;51(3):414-430
pubmed: 30820047
J Neuropathol Exp Neurol. 2003 Nov;62(11):1087-95
pubmed: 14656067
J Neurochem. 2017 Nov;143(4):396-408
pubmed: 28397252
Neurology. 2011 Nov 8;77(19):1737-44
pubmed: 22031532
Lancet Neurol. 2013 Jan;12(1):92-104
pubmed: 23237904
N Engl J Med. 2009 May 28;360(22):2302-9
pubmed: 19474427
Neurology. 2015 Aug 11;85(6):535-42
pubmed: 26180144
J Neurosci. 2007 Dec 26;27(52):14459-69
pubmed: 18160654
Neuron. 2013 Jan 23;77(2):219-34
pubmed: 23352159
Brain. 2015 May;138(Pt 5):1370-81
pubmed: 25805643
Mol Psychiatry. 2015 Dec;20(12):1588-95
pubmed: 25687773
Neurology. 2002 Jun 25;58(12):1791-800
pubmed: 12084879
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248
PLoS One. 2017 Oct 23;12(10):e0186413
pubmed: 29059208
Lancet. 2001 Jan 20;357(9251):169-75
pubmed: 11213093

Auteurs

Orso Bugiani (O)

Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133, Milano, Italy. orso.bugiani@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH